714208
L-醛赖氨酸乙烯乙缩醛
≥98% (TLC)
别名:
(S)-2-氨基-5-(1,3-二氧戊环-2-基)戊酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C8H15NO4
化学文摘社编号:
分子量:
189.21
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352209
MDL number:
Quality Level
assay
≥98% (TLC)
form
crystals
optical activity
[α]/D +4.0±0.3°, c = 1 in H2O
reaction suitability
reaction type: solution phase peptide synthesis
application(s)
peptide synthesis
SMILES string
N[C@@H](CCCC1OCCO1)C(O)=O
InChI
1S/C8H15NO4/c9-6(8(10)11)2-1-3-7-12-4-5-13-7/h6-7H,1-5,9H2,(H,10,11)/t6-/m0/s1
InChI key
RQULWPSGQYZREI-LURJTMIESA-N
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Michael F Wempe et al.
Journal of inherited metabolic disease, 42(3), 565-574 (2019-01-22)
Pyridoxine-dependent epilepsy (PDE) is often characterized as an early onset epileptic encephalopathy with dramatic clinical improvement following pyridoxine supplementation. Unfortunately, not all patients present with classic neonatal seizures or respond to an initial pyridoxine trial, which can result in the
Elizabeth Mary Mathew et al.
International journal of analytical chemistry, 2018, 2583215-2583215 (2018-08-30)
Pyridoxine dependent epilepsy is a condition where the affected infant or child has prolonged seizures (status epilepticus), which are nonresponsive to anticonvulsant therapy but can be treated with pharmacological doses of pyridoxine. If identified earlier and treated prophylactically with pyridoxine
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 714208-250MG | 04061832596174 |